我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

急性冠脉综合征患者外周血MMP-9及CRP的变化及其临床意义(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2006年第3期
页码:
318-319,322
栏目:
临床研究
出版日期:
2006-06-25

文章信息/Info

Title:
Changes and implication of peripheral blood levels of matrix metalloproteases9 and Creactive protein in patients with acute coronary syndromes
作者:
殷忠李兰荪张荣庆刘安恒栾荣华王海昌
第四军医大学西京医院心内科,陕西 西安 710033
Author(s):
YIN Zhong LI Lan-sun ZHANG Rong-qing LIU An-heng LUAN Rong-hua WANG Hai-chang
Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi′an,Shaanxi 710032, China
关键词:
急性冠脉综合征心肌梗塞急性不稳定型心绞痛稳定型心绞痛基质金属蛋白酶-9C反应蛋白
Keywords:
acute coronary syndromesmyocardial infarctionacuteunstable anginastable anginamatrix metalloprotease-9C-reactive protein
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的 观察急性冠脉综合征(ACS)患者外周血中基质金属蛋白酶-9(matrix metalloproteases-9,MMP-9)及C反应蛋白(CRP)的水平变化,探讨MMP-9、CRP与ACS发生的关系。方法 选取ACS患者39例,采用双抗体夹心ELISA测定血清MMP-9的水平,CRP用免疫散射比浊法检测。结果 ACS患者入院即刻血浆MMP-9 、CRP水平均显著高于对照组[(66±16) vs (24±11) μg/L,P<0.01;(12.3±9.2) vs (3.5±2.0) mg/L,P<0.01]。 ACS组内UA亚组与AMI亚组比较,MMP9水平显著增高[(78±11) vs (50±14) μg/L,P<0.01],而CRP水平显著下降[(7.2±2.2) vs (18.7±10.7) mg/L,P<0.01]。ACS组患者中MMP9和CRP水平无明显相关性。结论 冠心病患者外周血MMP-9、CRP水平升高。ACS患者中MMP-9和CRP水平无明显相关性。
Abstract:
AIM To investigate whether peripheral blood levels of matrix metalloproteases-9 (MMP-9) and Creactive protein(CRP)are affected in patients with acute coronary syndromes (ACS). METHODS Using enzymelinked immunosorbent assay (ELISA) and scatter rate nephelometry, serum MMP-9 and CRP were measured in 39 patients with ACS. RESULTS The serum levels of MMP-9 and CRP in ACS group were significantly higher than those in control groups (P<0.01). In ACS group, the serum level of MMP-9 was higher in UA subgroup than that in AMI subgroup (P<0.01) and CRP was higher in AMI subgroup than that in UA subgroup (P<0.01). But no significant correlation was found between MMP-9 and CRP in ACS group. CONCLUSION The serum levels of MMP-9 and CRP in patients with coronary artery disease increase and there is no correlation between MMP-9 and CRP.

参考文献/References

[1] Falk E, Shah PK,Fuster V. Coronary plaque disruption[J]. Circulation,1995,92 (3):657-671.

[2] Dollery CM, McEwan JR,Henney AM. Matrix metalloproteases and cardiovascular disease[J]. Circ Res, 1995,77(5):863–868.

[3] Ross R. Atherosclerosis——an inflammatory disease[J]. N Engl J Med,1999,340(2):115-126.

[4] 许俊堂,胡大一. 对急性冠脉综合征分型的看法[J]. 中华心血管杂志,2001,29(9):566-568.

[5] Sukhova GK,Schonbeck U,Rabkin E. Evidence for increased collagenolysis by interstitial collagenases1 and 3 in vulnerable human atheromatous laques[J]. Circulation,1999,99(19):2503-2509.

[6] Herman MP,Sukhova GK,Libby P. Expression of neutrophil collagenase(matrix metalloprotease8) in human atheroma :a novel collagenic pathway suggested by transcriptional profiling[J]. Circulation,2001,104(16):1899-1904.

[7] Kai H,Ikeda H,Yasukawa H,et al. Peripheral blood levels of matrix metalloproteinases2 and 9 are elevated in pations with acute coronary syndrome[J]. J Am Coll Cardiol,1998,32(2):368-372.

[8] 罗明,俞文萍,王宏保. 辛伐他汀联合依那普利干预对急性冠脉综合征患者血清C反应蛋白和白介素6的影响[J]. 心脏杂志,2005,17(2):137-139.

[9] Saren P.Welgus HG,Kovanen PT. TNFα and IL1β selectively induce expression of 92kDa gelatinase by human macrophages[J]. J Immunol,1996,157(9):4159-4165.

[10]Cahill MR,Perry IJ. Inflammation,aspirin,and the risk of cardiovascular disease[J]. N Engl J Med,1997,337(6):422-423.

备注/Memo

备注/Memo:
收稿日期:2005-08-03.通讯作者:李兰荪,主任医师,教授,主要从事冠心病的诊断及治疗研究 Tel:(029)84775563 作者简介:殷忠,住院医师,硕士生 Tel:(029)82554077 Email:ouandyin@fmmu.edu.cn
更新日期/Last Update: